executive · October 8, 2026
How Nashiah Turns Commercial Signals Into Governed Decisions
By Nashiah
Pharmaceutical commercial teams already have access to data across media platforms, social media analytics, CRM, website analytics, campaign systems, reach and frequency data, brand performance reports, and agency systems. However, this information often remains fragmented across separate platforms, making it difficult to understand what changed, why it matters, and what action should follow.
Nashiah helps pharma brands establish a dedicated brand data lake that brings together commercial and media data from multiple sources. This centralized foundation organizes information for reporting, analysis, and AI use cases, creating a stronger foundation for brand intelligence.
On top of the brand data lake, Nashiah supports automated recurring commercial reporting. Monthly and quarterly reports can cover media performance, reach and frequency, campaign performance, channel performance, engagement trends, and brand-level insights. This shifts teams away from manually collecting data and preparing recurring reports toward a more structured, automated reporting process.
The next step is moving beyond reporting to decision support. Traditional reports explain what happened, what changed, and what performed well or underperformed. An agentic workforce can help identify what needs attention, explain why it matters, recommend potential actions, and identify who should review or approve them.
Nashiah builds AI agents on top of the brand data lake to monitor commercial signals, analyze data continuously, identify opportunities and risks, and recommend next-best actions. Six specialized agents support different commercial needs: the Brand Excellence Agent monitors brand performance and opportunities; the Media Performance Agent reviews campaign and media signals; the Reporting Agent prepares recurring commercial reports; the Next-Best-Action Agent recommends subsequent actions; the HCP Engagement Agent helps identify valuable engagement signals; and the Commercial Operations Agent supports governance, tracking, and follow-up.
These agents help connect media traffic and engagement signals to commercial insights, next-best actions, human review, and HCP-focused follow-up. The objective is to help commercial teams identify which signals should translate into meaningful action rather than treating every data point as an isolated observation.
Human oversight remains central to this operating model. AI agents can monitor, analyze, and recommend, while people retain responsibility for important decisions. Human review, approval requirements, traceable decisions, and governance built into workflows help maintain accountability as AI-supported commercial operations evolve.
Nashiah's approach extends beyond individual AI use cases. Its capabilities include brand-specific data lakes, cloud-based hosting, brand website support, 24/7 operational support, automated reporting, AI agents and workflows, AI-based operating model design, and commercial technology modernization. Together, these capabilities support a more connected approach to pharmaceutical commercial operations.
The journey from a brand data lake to an agentic workforce follows three steps: build a trusted brand data foundation, automate reporting and commercial intelligence, and use AI agents to turn signals into governed next-best actions. The goal is to help pharma brands move from fragmented data and manual reporting toward AI-supported commercial action.
Video
Presentation slides
PowerPoint file (.pptx)
